Clement A. Meseda

832 total citations
32 papers, 656 citations indexed

About

Clement A. Meseda is a scholar working on Epidemiology, Virology and Molecular Biology. According to data from OpenAlex, Clement A. Meseda has authored 32 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 17 papers in Virology and 12 papers in Molecular Biology. Recurrent topics in Clement A. Meseda's work include Poxvirus research and outbreaks (17 papers), Herpesvirus Infections and Treatments (14 papers) and Bacillus and Francisella bacterial research (10 papers). Clement A. Meseda is often cited by papers focused on Poxvirus research and outbreaks (17 papers), Herpesvirus Infections and Treatments (14 papers) and Bacillus and Francisella bacterial research (10 papers). Clement A. Meseda collaborates with scholars based in United States, United Kingdom and Netherlands. Clement A. Meseda's co-authors include Jerry P. Weir, Michael Merchlinsky, Alonzo D. García, Hana Golding, M. Mackett, Carol D. Weiss, Lisa R. King, Jody Manischewitz, Karen L. Elkins and A. Mayer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Clement A. Meseda

32 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clement A. Meseda United States 15 430 328 250 203 114 32 656
J. F. Kaye United Kingdom 10 504 1.2× 244 0.7× 284 1.1× 161 0.8× 116 1.0× 10 810
Vijay Panchanathan Australia 11 302 0.7× 350 1.1× 165 0.7× 311 1.5× 73 0.6× 14 568
Yasemin Suezer Germany 16 510 1.2× 245 0.7× 175 0.7× 366 1.8× 191 1.7× 20 854
Annalena La Porte United States 8 242 0.6× 553 1.7× 320 1.3× 451 2.2× 204 1.8× 11 864
Lori F. Maxfield United States 8 134 0.3× 255 0.8× 271 1.1× 175 0.9× 149 1.3× 11 541
J. Tartaglia United States 13 273 0.6× 443 1.4× 187 0.7× 411 2.0× 122 1.1× 21 742
Derek D. Drummond United States 6 608 1.4× 309 0.9× 140 0.6× 416 2.0× 157 1.4× 8 915
Joëlle Tobaly-Tapiero France 17 275 0.6× 407 1.2× 265 1.1× 146 0.7× 153 1.3× 29 792
Maureen F. Maughan United States 12 253 0.6× 226 0.7× 268 1.1× 360 1.8× 314 2.8× 17 840
April J. Schumacher United States 8 387 0.9× 474 1.4× 339 1.4× 195 1.0× 273 2.4× 10 827

Countries citing papers authored by Clement A. Meseda

Since Specialization
Citations

This map shows the geographic impact of Clement A. Meseda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clement A. Meseda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clement A. Meseda more than expected).

Fields of papers citing papers by Clement A. Meseda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clement A. Meseda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clement A. Meseda. The network helps show where Clement A. Meseda may publish in the future.

Co-authorship network of co-authors of Clement A. Meseda

This figure shows the co-authorship network connecting the top 25 collaborators of Clement A. Meseda. A scholar is included among the top collaborators of Clement A. Meseda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clement A. Meseda. Clement A. Meseda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stauft, Charles B., Prabhuanand Selvaraj, Felice D’Agnillo, et al.. (2023). Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants. Nature Communications. 14(1). 3393–3393. 8 indexed citations
2.
Meseda, Clement A., et al.. (2023). Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4. Influenza and Other Respiratory Viruses. 17(5). e13152–e13152. 3 indexed citations
3.
Liu, Shufeng, Charles B. Stauft, Prabhuanand Selvaraj, et al.. (2022). Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters. Nature Communications. 13(1). 6792–6792. 11 indexed citations
4.
Kim, Jae‐Kwan, Clement A. Meseda, Krishnamurthy Konduru, et al.. (2022). EnhancedIn VitroandIn VivoPotency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions. Journal of Virology. 96(18). e0116621–e0116621. 1 indexed citations
5.
Meseda, Clement A., Charles B. Stauft, Prabhuanand Selvaraj, et al.. (2021). MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge. npj Vaccines. 6(1). 145–145. 15 indexed citations
6.
Meseda, Clement A., Maryna C. Eichelberger, Jin Gao, et al.. (2018). Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase. Scientific Reports. 8(1). 5364–5364. 15 indexed citations
7.
8.
Verma, Swati, et al.. (2015). Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge. PLoS ONE. 10(1). e0117108–e0117108. 31 indexed citations
9.
Meseda, Clement A., Kumar Srinivasan, Jasen Wise, et al.. (2014). Non-coding RNAs and heme oxygenase-1 in vaccinia virus infection. Biochemical and Biophysical Research Communications. 454(1). 84–88. 2 indexed citations
10.
11.
He, Yong, Clement A. Meseda, Russell Vassell, et al.. (2009). Recombinant A27 protein synergizes with modified vaccinia Ankara in conferring protection against a lethal vaccinia virus challenge. Vaccine. 28(3). 699–706. 1 indexed citations
12.
He, Yong, Jody Manischewitz, Clement A. Meseda, et al.. (2007). Antibodies to the A27 Protein of Vaccinia Virus Neutralize and Protect against Infection but Represent a Minor Component of Dryvax Vaccine–Induced Immunity. The Journal of Infectious Diseases. 196(7). 1026–1032. 27 indexed citations
13.
Laassri, Majid, et al.. (2007). Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene. Journal of Medical Virology. 79(6). 791–802. 9 indexed citations
14.
Meseda, Clement A., Richard Stout, & Jerry P. Weir. (2006). Evaluation of a Needle-Free Delivery Platform for Prime-Boost Immunization with DNA and Modified Vaccinia Virus Ankara Vectors Expressing Herpes Simplex Virus 2 Glycoprotein D. Viral Immunology. 19(2). 250–259. 12 indexed citations
15.
Edghill‐Smith, Yvette, Mike Bray, Chris A. Whitehouse, et al.. (2005). Smallpox Vaccine Does Not Protect Macaques with AIDS from a Lethal Monkeypox Virus Challenge. The Journal of Infectious Diseases. 191(3). 372–381. 75 indexed citations
16.
García, Alonzo D., Clement A. Meseda, Yong He, et al.. (2005). Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin. Virology. 343(1). 128–140. 40 indexed citations
17.
18.
Meseda, Clement A., et al.. (2003). DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome. Virology. 318(1). 420–428. 26 indexed citations
19.
Meseda, Clement A., Karen L. Elkins, Michael Merchlinsky, & Jerry P. Weir. (2002). Prime‐Boost Immunization with DNA and Modified Vaccinia Virus Ankara Vectors Expressing Herpes Simplex Virus–2 Glycoprotein D Elicits Greater Specific Antibody and Cytokine Responses than DNA Vaccine Alone. The Journal of Infectious Diseases. 186(8). 1065–1073. 48 indexed citations
20.
Khanim, Farhat L., M. Mackett, Lawrence S. Young, et al.. (1997). BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates.. Journal of General Virology. 78(11). 2987–2999. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. F. Kaye Breakdown of academic impact, for papers by Vijay Panchanathan Breakdown of academic impact, for papers by Yasemin Suezer Breakdown of academic impact, for papers by Annalena La Porte Breakdown of academic impact, for papers by Lori F. Maxfield Breakdown of academic impact, for papers by J. Tartaglia Breakdown of academic impact, for papers by Derek D. Drummond Breakdown of academic impact, for papers by Joëlle Tobaly-Tapiero Breakdown of academic impact, for papers by Maureen F. Maughan Breakdown of academic impact, for papers by April J. Schumacher
Rankless by CCL
2026